<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112647">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01912066</url>
  </required_header>
  <id_info>
    <org_study_id>DA9601_PG_IV</org_study_id>
    <nct_id>NCT01912066</nct_id>
  </id_info>
  <brief_title>A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601</brief_title>
  <official_title>A Phase IV Clinical Trial to Evaluate the Preventive Effectiveness of NSAID-Associated Gastroduodenal Injury (Multi-center, Double-blind, Active-controlled, Stratified Randomized, Parallel Group)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong-A Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dong-A Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase IV clinical study to evaluate the preventive effectiveness of
      NSAID-Associated Gastroduodenal Injury. The study is consisted of multi-center, doubleblind,
      active-controlled, stratified randomized, parallel group. A tablet of DA9601, Cytotec (200ug
      of Misoprostol), Acrofen (100mg of Aceclofenac) will be assigned randomly to the subjects
      for four weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After filling an Informed consent form, subjects are joined the clinical trials. First of
      all, Screening test including the endoscopy test is performed.

      Subjects, which fit the inclusion/Exclusion criteria, are assigned randomly. Subjects takes
      investigation products as randomized.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>the percentage of protected subjects (%)</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>the definition of &quot;protected&quot; is the subjects with no erosions, in other words, either zero or 1 erosion found at stomach by the endoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>A percentage of a protected subject (at duodenum), and of ulcer occurrence</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The definition of &quot;protected&quot; is the subjects with no erosions, in other words, either zero or 1 erosion found at duodenum by the endoscopy.
A percentage of ulcer occurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">468</enrollment>
  <condition>NSAID-associated Gastroduodenal Injury</condition>
  <arm_group>
    <arm_group_label>Stillen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients taking a tab of Stillen and a tab of placebo drug and a tab of NSAID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cytotec</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The subjects taking a tab of Cytotec, a tab of placebo drug, and a tab of NSAID</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stillen</intervention_name>
    <arm_group_label>Stillen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cytotec (reference drug)</intervention_name>
    <arm_group_label>Cytotec</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NSAID (Aceclofenac)</intervention_name>
    <arm_group_label>Stillen</arm_group_label>
    <arm_group_label>Cytotec</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Need to take NSAID pills for longer than four weeks

          -  should be normal diagnosed by the endoscopy test

        Exclusion Criteria:

          -  The patients have gastric ulcer or duodenal ulcer within 30 days

          -  The patients have a gastro-intestinal surgery within a year

          -  The patients are taking the following drugs within seven days: H2 receptor
             antagonist, PPI, sucralfate, misoprostol, Stillen etc)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang-Yong Seol, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Myoung-Gyu Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oh Young Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Ho Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Chan Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suck Chei Choi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wonkwang University School of Medicine &amp; Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong Sun Rew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kang Moon Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea ST.Vincent's hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jae Young Jang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyunghee University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hoon-jai Chun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Anam Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sang-woo Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moo In Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kosin University Gospel Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joong Goo Kwon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daegu Catholic University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Geunam Song, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seong Woo Jeon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Soo Taek Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonbuk National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jae Gyu Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Poong-Lyul Rhee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kwang Jae Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyo Jin Park, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gangnam Severance Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Byung Ik Jang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Woon Shin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Soo Han, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sung Kook Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang-Yong Seol, MD</last_name>
    <phone>01038518503</phone>
    <email>seolsymd@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sohee Son</last_name>
    <phone>0518908950</phone>
    <phone_ext>01026290662</phone_ext>
    <email>soheewkd@busanpaik.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Inje University Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <zip>614735</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sohee Son</last_name>
      <phone>0518908950</phone>
      <phone_ext>01026290662</phone_ext>
      <email>soheewkd@busanpaik.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Jiyoung Kim</last_name>
      <phone>0518908957</phone>
      <phone_ext>01031866074</phone_ext>
      <email>sunflower0315@busanpaik.ac.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Sang-Yong Seol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 29, 2013</lastchanged_date>
  <firstreceived_date>July 25, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
